MaxLinear price target lowered to $22 from $30 at Susquehanna

Susquehanna lowered the firm’s price target on MaxLinear to $22 from $30 and keeps a Positive rating on the shares. The firm said while they knew there was a lot of inventory out there, guidance implies something below their worse case and while it still may take a few more quarters, the 2H24 snapback could be meaningful off this huge drawdown.